Letter to editor/comment
- PMID: 31353784
- DOI: 10.1111/tbj.13469
Letter to editor/comment
Comment in
-
Reply-Letter to the editor.Breast J. 2019 Nov;25(6):1332. doi: 10.1111/tbj.13478. Epub 2019 Jul 28. Breast J. 2019. PMID: 31353773 No abstract available.
Comment on
-
Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease.Breast J. 2019 May;25(3):418-424. doi: 10.1111/tbj.13234. Epub 2019 Mar 29. Breast J. 2019. PMID: 30925636
References
REFERENCES
-
- Takala S, Heikkila P, Nevanlinna H, Blomqvist C, Mattson J. Metaplastic carcinoma of the breast: prognosis and response to systemic treatment in metastatic disease. Breast J. 2019;25(3):418-424.
-
- Zhai J, Giannini G, Ewalt MD, et al. Molecular characterization of metaplastic breast carcinoma via next generation sequencing. Hum Pathol. 2018;86:85-92.
-
- Joneja U, Vranic S, Swensen J, et al. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1. J Clin Pathol. 2017;70(3):255-259.
-
- McCart Reed AE, Kalaw E, Nones K, et al. Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications. J Pathol. 2019;247(2):214-227.
-
- Krings G, Chen YY. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma. Mod Pathol. 2018;31(11):1661-1674.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical